Home Newsfeeds Raymond James Downgrades Invitae to Market Perform

Raymond James Downgrades Invitae to Market Perform

Raymond James analyst Andrew Cooper downgrades Invitae (NYSE:NVTA) from Outperform to Market Perform.

byBenzinga Newsdesk

July 21, 2022

1 minute read

Raymond James analyst Andrew Cooper downgrades Invitae (NYSE:NVTA) from Outperform to Market Perform.

Analyst Ratings

Where Allogene Therapeutics Stands With Analysts

By Benzinga Insights

April 18, 10:00 AM

Analysts have provided the following ratings for Allogene Therapeutics (NASDAQ:ALLO) within the last quarter: Bullish Somewhat Bullish Indifferent…

ALLO

Trinidad’s Shallow Water Auction: BP, Shell, EOG Reportedly Placed Bet Lured By New Terms

By Lekha Gupta

May 28, 6:42 AM

BP, Shell, EOG bid on 4 blocks for oil and gas exploration in Trinidad's 2023 auction. No other bidders, results in 4 months. Trinidad makes changes to attract bids.

Reported Late Monday April 17, U.S. FDA Approves AbbVie’s QULIPTA For Adults With Chronic Migraine

By Happy Mohamed

April 18, 12:25 AM

QULIPTA® now the first and only oral CGRP receptor antagonist approved to prevent migraine across frequencies, including episodic and chronic Expanded indication provides an additional treatment option for

ABBV